| Brain MR radiomics to differentiate cognitive disorders S Ranjbar, SN Velgos, AC Dueck, YE Geda, JR Mitchell, ... The Journal of neuropsychiatry and clinical neurosciences 31 (3), 210-219, 2019 | 27 | 2019 |
| Probing Antibody-Antigen Interactions SMR Yang G, Velgos SN, Boddapati SP Microbiol Spectr. 2 (1), 2014 | 14* | 2014 |
| Interaction between BDNF Val66Met and APOE4 on biomarkers of Alzheimer’s disease and cognitive decline CM Stonnington, SN Velgos, Y Chen, S Syed, M Huentelman, ... Journal of Alzheimer's Disease 78 (2), 721-734, 2020 | 11 | 2020 |
| Deep brain stimulation and cognitive outcomes among patients with Parkinson’s disease: a historical cohort study AL Hansen, J Krell-Roesch, KA Kirlin, MM Limback-Stokin, K Roesler, ... The Journal of Neuropsychiatry and Clinical Neurosciences 31 (3), 196-200, 2019 | 6 | 2019 |
| Association of pancreatic polypeptide with mild cognitive impairment varies by APOE ε4 allele RO Roberts, JA Aakre, RH Cha, WK Kremers, MM Mielke, SN Velgos, ... Frontiers in aging neuroscience 7, 172, 2015 | 6 | 2015 |
| Sanger Sequencing Exons of BDNF Gene Derived from a Latino Sample (P2. 144) S Dawit, J Acosta, M Champion, S Velgos, G Shaibi, L Mandarino, ... Neurology 82 (10_supplement), P2. 144, 2014 | 1 | 2014 |
| Antibody Based Therapeutic for Parkinson's Disease RM Glaspie, S Velgos, S Emadi, M Sierks The 2007 Annual Meeting, 2007 | | 2007 |
